PerkinElmer
1920x400_014436A_01.jpg

Application Note

Analysis of Allergy Medications Using ICP-OES Following USP 232/233 Guidelines with Software Designed to Aid in 21 CFR Part 11 Compliance

Introduction

This work demonstrates the ability of the Avio 500 ICP-OES to meet the USP <232>/<233> criteria for the analysis of orally-administered allergy tablets using Syngistix for ICP Enhanced Security software version 4.0, which provides the tools to help laboratories meet 21 CFR Part 11 compliance.